Global Throat Cancer Market Anticipated to Expand Rapidly From 2025 to 2029

 Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

 

 What Are the Key Growth Indicators and Market Expansion Estimates for the Throat Cancer Market Through 2029?
 The throat cancer market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to an increase in the smoking population, growing alcohol abuse, rising human papillomavirus (HPV) infections, rising prevalence of gastroesophageal reflux disease, and growing urban air pollution.
 
 The throat cancer market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the rise in demand for personalized medicine, rising adoption of tele-oncology and diagnostics, rising genetic profiling and biomarker adoption, rising use of e-cigarettes and vaping, and rising sedentary lifestyle and obesity rates. Major trends in the forecast period include advancements in treatment techniques, inclusion of novel technologies in diagnostic equipment, development of new drugs and therapies, integration of artificial intelligence and machine learning in predictive diagnostics, and integration of speech therapy with digital platforms.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24722&type=smp
 
 Which Key Drivers Are Fueling Growth in the Throat Cancer Market?
 The increase in the smoking population is expected to propel the growth of the throat cancer market going forward. Smoking population refers to the percentage or number of individuals in a given area who regularly smoke tobacco products. The smoking population is increasing due to rising stress levels, which lead more individuals to adopt smoking as a coping mechanism. Throat cancer serves as a stark reminder of the severe health risks associated with smoking, highlighting the urgent need for public awareness and preventive measures to reduce its prevalence in smoking populations. For instance, in October 2024, according to the European Respiratory Society (ERS), a Switzerland-based non-profit organization, a study covering smoking trends among young people revealed a significant rise in smoking rates, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024. Therefore, the increase in the smoking population is driving the growth of the throat cancer market.
 
 How Is the Throat Cancer Market Categorized Based on Key Segments?
 The throat cancer market covered in this report is segmented — 
 
 1) By Types: Pharyngeal Cancer, Laryngeal Cancer
 2) By Treatments: Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Antimetabolites, Platinum Derivatives, Plant Derivatives, Nitrogen Mustards, Antibiotics, Other Treatments
 3) By End-User: Hospitals, Cancer Research Institutes, Multispecialty Clinics, Ambulatory Surgical Centers
 
 Subsegments 
 1) By Pharyngeal Cancer: Oropharyngeal Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer
 2) By Laryngeal Cancer: Glottic Cancer, Supraglottic Cancer, Subglottic Cancer
 
 Which Disruptive Trends Are Reshaping the Competitive Landscape of the Throat Cancer Market?
 Major companies operating in the throat cancer market are focusing on developing innovative therapies, such as immuno-oncology drugs, to enhance treatment efficacy and improve patient survival outcomes. Immuno-oncology drugs refer to treatments that use the body’s immune system to identify and attack cancer cells, offering a targeted approach to combat throat cancer. For instance, in November 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab for treating nasopharyngeal carcinoma, a rare form of throat cancer. This groundbreaking therapy harnesses the power of immune checkpoint inhibition by targeting the PD-1 receptor, helping the body’s immune system recognize and attack cancer cells more effectively. Toripalimab offers a novel treatment option for a rare and aggressive form of cancer that has limited therapeutic choices, potentially improving survival rates and quality of life for patients.
 
 Who Are the Leading Market Participants in the Throat Cancer Market?
 Major companies operating in the throat cancer market are Pfizer Inc., Roche Holding AG, Merck and Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Dr. Reddy’s Laboratories, Biocon Ltd., Coherus BioSciences Inc., Inovio Pharmaceuticals Inc., Boston Biomedical Inc., Shanghai Sunway Biotech Co. Ltd., Odon Life Sciences. 
 
 Get the detailed throat cancer market report today
 https://www.thebusinessresearchcompany.com/report/throat-cancer-global-market-report
 
 Which Regions Are Driving the Highest Demand in the Throat Cancer Market?
 North America was the largest region in the throat cancer market in 2024. The regions covered in the throat cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company